Vivaldi Biosciences Inc
Nasal-spray self-adjuvanting vaccines using Delta NS1 technology platform for viral respiratory diseases
- Sector
- Biotech
- Headquarters
- New York, NY
- Founded
- 2006
- Latest Form D
- $2M, Jul 2010
- Total capital
- $2M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $2M
- 1 Form D · last Jul 2010
- 196 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 3 pending · first 2025
- Rank in peer group#481 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#481 · top 33%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Adolfo O. Garcia-Sastre, Ph.D.PromoterNamed in SEC Form D filings
- David LiebowitzExecutive Officer, PromoterNamed in SEC Form D filings
- Douglass GivenExecutive Officer, DirectorNamed in SEC Form D filings
- Elliott O. Kieff, M.D.PromoterNamed in SEC Form D filings
- Georg NebgenDirectorNamed in SEC Form D filings
- N/A O. Bay City Capital Fund IV Co-Investment Fund, L.P.PromoterNamed in SEC Form D filings
Show all 14 people
- N/A O. Bay City Capital Fund IV, L.P.PromoterNamed in SEC Form D filings
- N/A O. Douglass B. and Kim Given Revocable Trust, U/A/D 8/11/01PromoterNamed in SEC Form D filings
- N/A O. Scheer Investment Holdings IX LLCPromoterNamed in SEC Form D filings
- Peter JohannDirectorNamed in SEC Form D filings
- Peter O. Palese, Ph.D.PromoterNamed in SEC Form D filings
- Vic SchmittDirectorNamed in SEC Form D filings
- William GerberDirectorNamed in SEC Form D filings
- William O. Wick, Jr.Executive Officer, PromoterNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 4- GrantedNovel Prime-boost Influenza VaccineUSPTOUS 12,447,204
- PendingInfluenza Virus Encoding A Truncated NS1 Protein And A Sars-cov Receptor Binding DomainUSPTOApplication 18036631
- PendingNovel Prime-boost Influenza VaccineUSPTOApplication PCTUS2020066049
Show all 4 patent records
- Novel Prime-boost Influenza VaccineOct 21, 2025 · US 12,447,204Granted
- Influenza Virus Encoding A Truncated NS1 Protein And A Sars-cov Receptor Binding DomainDec 28, 2023 · Application 18036631Pending
- Novel Prime-boost Influenza VaccineApplication PCTUS2020066049Pending
- Influenza Virus Encoding A Truncated NS1 Protein And A Sars-cov Receptor Binding DomainApplication 63114941Pending
Related companies, and why
- TripleBar Bio, Inc.Similar federal contract value in Biotech · null in contracts
- Capacity Bio, Inc.Similar federal contract value in Biotech · null in contracts
- ENTRINSIC HEALTH SOLUTIONS, INC.Similar federal contract value in Biotech · null in contracts
- PAION AGSimilar federal contract value in Biotech · null in contracts
- Q32 BioSimilar federal contract value in Biotech · null in contracts
- Mytos, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .